title: Myelodysplastic syndromes.
abstract: The myelodysplastic syndromes are a diverse group of clonal stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and an increased propensity to evolve to acute myeloid leukemia. The molecular pathogenesis of these disorders is poorly understood, but recurring chromosomal abnormalities occur in approximately 50% of cases and are the focus of much investigation. The availability of newer molecular techniques has allowed the identification of additional genetic aberrations, including mutations and epigenetic changes of prognostic and potential therapeutic importance. This review focuses on the key role of cytogenetic analysis in myelodysplastic syndromes in the context of the diagnosis, prognosis, and pathogenesis of these disorders.
authors: Department of Medicine, Section of Hematology/Oncology, University of Chicago, 5841 South Maryland, MC2115, Chicago, IL 60637, USA.
authors: Olatoyosi
authors: O
authors: Odenike
authors: John
authors: J
authors: Anastasi
authors: Michelle M
authors: MM
authors: Le Beau
mesh_terms: D002869:Chromosome Aberrations; D020732:Cytogenetic Analysis; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000235:genetics*; D011379:Prognosis